|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
JPRN |
|
Last refreshed on:
|
17 October 2023 |
|
Main ID: |
JPRN-UMIN000018642 |
|
Date of registration:
|
11/08/2015 |
|
Prospective Registration:
|
Yes |
|
Primary sponsor: |
|
|
Public title:
|
A trial of fecal microbiota transplantation and / or antibiotics therapy for ulcerative colitis
|
|
Scientific title:
|
A trial of fecal microbiota transplantation and / or antibiotics therapy for ulcerative colitis - A trial of fecal microbiota transplantation and / or antibiotics therapy for ulcerative colitis |
|
Date of first enrolment:
|
2015/08/12 |
|
Target sample size:
|
50 |
|
Recruitment status: |
Complete: follow-up complete |
|
URL:
|
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000021579 |
|
Study type:
|
Interventional |
|
Study design:
|
Parallel Non-randomized
|
|
Phase:
|
Not selected
|
|
|
Countries of recruitment
|
|
Japan
| | | | | | | |
|
Contacts
|
|
Name:
|
Dai Ishikawa |
|
Address:
|
2-1-1Hongo, Bunkyoku Tokyo
Japan |
|
Telephone:
|
03-3813-3111 |
|
Email:
|
dai@juntendo.ac.jp |
|
Affiliation:
|
Juntendo university school of medicine Department of gastroenterology |
|
|
Name:
|
Dai Ishikawa |
|
Address:
|
2-1-1Hongo, Bunkyoku Tokyo
Japan |
|
Telephone:
|
03-3813-3111 |
|
Email:
|
dai@juntendo.ac.jp |
|
Affiliation:
|
Juntendo university school of medicine Department of gastroenterology |
| |
|
Key inclusion & exclusion criteria
|
Inclusion criteria:
Exclusion criteria: 1. Patients who have severe drug allergy are excluded. 2. Donors who show abnormal findings to the screening tests including blood and feces.
Age minimum:
6years-old
Age maximum:
Not applicable
Gender:
Male and Female
|
|
Health Condition(s) or Problem(s) studied
|
|
ulcerative colitis
|
|
Intervention(s)
|
Antibiotics therapy:Taking three kinds of antibiotics (Amoxicillin, fosmycin, metronidazole) for two weeks.
FMT:Administration of the fecal material from healthy donors to patients.
|
|
Primary Outcome(s)
|
|
Efficacy of this treatment is evaluted by microbiota analysis, endoscopic score and bllod test.
|
|
Source(s) of Monetary Support
|
|
Juntendo university school of medicine Department of gastroenterology
|
|
Ethics review
|
Status: YES
Approval date: 31/07/2015
Contact:
|
|
Results
|
|
Results available:
|
Yes |
|
Date Posted:
|
|
|
Date Completed:
|
31/08/2016 |
|
URL:
|
|
|
|